Mu Opioid Receptor Polymorphisms and Variability in Opioid Actions

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/299050

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The treatment of pain in cancer patients is not optimal nor is the use of substitution therapy in heroin addiction. What links these two treatments is a group of drugs known as opioids- morphine for pain and methadone for dependence. People differ substantially in the dose of these two drugs to treat these conditions and the reasons for such large differences are not known. This application seeks to explore the role of genetic variations in the target site at which opioids act in explaining why people differ in their response to these medicines. Studies on humans and cell preparations will allow one to study the basic mechanisms and then translate this into the actual clinical setting. If successful, the results could mean better dose and medicine selection for people with pain and those seeking treatment for heroin addiction.

Funded Activity Details

Start Date: 01-01-2004

End Date: 01-01-2006

Funding Scheme: NHMRC Project Grants

Funding Amount: $239,250.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry - inorganic elements and compounds

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Chronic Pain | Clinical Pharmacology | Drug Dependence | Genetic Polymorphisms | Molecular Pharmacology | Morphine and methadone | Opioid Receptors | Pain Management

Related Links